Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/21364
Title: Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adolescent,Adult,Aged,Antineoplastic Agents/*administration & dosage/adverse effects/pharmacokinetics,Carcinoma, Non-Small-Cell Lung/*drug therapy,Child,Child, Preschool,Disease Progression,Drug Administration Schedule,Female,Glucose/analogs & derivatives,Humans,Ifosfamide/analogs & derivatives,Infusions, Intravenous,Lung Neoplasms/*drug therapy,Male,Middle Aged,Phosphoramide Mustards/*administration & dosage/adverse effects/pharmacokinetics,Prospective Studies
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/21364
ISSN: 0959-8049
Link: http://www.ncbi.nlm.nih.gov/pubmed/15010066
http://ac.els-cdn.com/S0959804903010232/1-s2.0-S0959804903010232-main.pdf?_tid=c680b9e32df178e8b0117c460615f4af&acdnat=1333703230_aeeebfce9f2e06f65faf8c90107a0fce
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Giaccone-2004-Glufosfamide adminis.pdf169.83 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons